fda approved semaglutide Approves Wegovy Weight-Loss Pill FDA approves higher-dose Wegovy to

3094 in the Eastern District of Pennsylvania, primarily alleging gastrointestinal injuries like gastroparesis and intestinal obstruction caused by drugs including Ozempic, Mounjaro, Wegovy, and Trulicity

As the reach of glucagon-like peptide-1 (GLP-1) medications such as Ozempic continue to expand in the United States and Canada, how those drugs influence mental health has become an urgent question

Rybelsus patients should continue their medication as directed and speak with their healthcare professionals about transitioning to the Ozempic pill, as appropriate

At this time, those with any form of government healthcare coverage (including programs such as Medicare, Medicaid or TRICARE), whether primary or secondary, or government-related coverage such as Medicare Supplement Plans, are not eligible for LifeMD GLP-1 weight loss programs, as these plans typically do not cover the type of medication LifeMD programs may prescribe

Duration: Typically resolves within 2-4 weeks without intervention